|
Dr. Douglas Hixson is vice president and co-founder of Prothera Biologics, a professor at Brown University, and the director of the COBRE Center for Cancer Research at Rhode Island Hospital. Dr. Hixson is known for his pioneering studies on liver progenitor cells. He has been a member and chair of numerous study sections for the NIH. Dr. Hixson is also a research professor of medicine and pathology at Brown University in Providence, Rhode Island. He earned a bachelor of science in mathematics in 1969, as well as a master’s degree in biochemistry in 1971 from Purdue University in West Lafayette, Indiana. In 1975, he earned his doctorate in biomedical sciences from the University of Texas in Houston. From 1998 to present, he has been the director of the Molecular Carcinogenesis Laboratory, Department of Medicine, Division of Medical Oncology, at Rhode Island Hospital.
| 